Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03625323
Title Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC (TACTI-002)
Acronym TACTI-002
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Immutep S.A.S.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | AUS

Facility Status City State Zip Country Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
Oncology Consultants Houston Texas 77030 United States Details
Tasman Health Care Southport Queensland 4215 Australia Details
St John of God Subiaco Hospital Perth WA 6008 Australia Details
Hospital de la Santa Creu i Sant Pau Barcelona 08025 Spain Details
Vall d' Hebron Institute of Oncology (VHIO) Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Consorci Corporació Sanitària Parc Taulí de Sabadell Barcelona 08208 Spain Details
Institut Català d'Oncologia Badalona-Hospital Germans Trias i Pujol Barcelona 08916 Spain Details
Hospital Universitario Lucus Augusti Lugo 27003 Spain Details
Fundación Jiménez Díaz Madrid 28040 Spain Details
Hospital Universitario HM Sanchinarro Madrid 28050 Spain Details
Hospital Regional Universitario de Málaga Málaga 29010 Spain Details
Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council Dnipro 49102 Ukraine Details
Medical and Diagnostic Centre of Private Enterprise of Private Manufacturing Company "Acinus" Kropyvnytskyi 25006 Ukraine Details
The Beatson West of Scotland Cancer Centre Glasgow United Kingdom Details
University College London Hospitals NHS Foundation London W1T 7HA United Kingdom Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field